The mission of NNECOS is to promote the highest quality care for patients with cancer and blood disorders in our region through professional networking, education, and scientific research, as well as patient advocacy and public policy.
UPCOMING EDUCATIONAL OPPORTUNITIES
Lunchtime webinar Series
Thursday, June 26th at 12:00pm
Oncology Nursing: Then, Now and into the Future
Anne M Ireland, DNP, RN, AOCN, CENP
This nursing continuing professional development activity has been approved by the Northeast Multistate Division Education Unit, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
OCN Review Course
NNECOS OCN Review Course
September 15, 2025 - Portland, ME
ANNUAL MEETING
NNECOS Annual Meeting October 24-25, 2025
RESEARCH, PROJECT & PROGRAM FUNDING
Fall Submission Deadline - September 15th
Fall Submission Deadline
October 15th
Up to $4,000 to fund your educational program.
Rolling Application Deadline
NNECOS PATIENT PHILANTHROPY
Rolling Application Deadline
Up to $3,000 per grant
Rolling Application Deadline
Up to 125, $25 grocery/cards
OTHER NEWS & INFORMATION
New! Patient Advisor!
NNECOS is delighted to announce the appointment of Tawnya McDonald as the inaugural NNECOS Patient/Caregiver Advisor. Tawnya will serve as a partner to the NNECOS Board of Directors, sharing feedback, generating ideas, and offering insight from a patient perspective, providing invaluable opinoins based on personal experience with aspects of care.
NNECOS Classifieds
Visit the NNECOS Member Classifieds for more information about job listings from the following centers:
Claim Issue Reported 1/8/25 impacting Part B providers in Jurisdiction JK and Jurisdiction J6 - Claims with healthcare common procedure coding system (HCPCS) G2211 with date of service (DOS) 1/1/2024-9/30/2024.
Effective for dates of service on or after April 1, 2024, the Centers for Medicare and Medicaid Services (CMS) has assigned the following Healthcare Common Procedure Coding System (HCPCS)* J-Code for ELREXFIO (elranatamab-bccm) injection: